Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk of Hepatic Cancers”

187 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 187 results

Not applicableStudy completedNCT05635279
What this trial is testing

Effect of Nutritional Indices on the Prognosis of HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Juan Kang 150
Not applicableWithdrawnNCT01831037
What this trial is testing

The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study

Who this might be right for
Chronic Hepatitis CChronic Hepatitis B
University of Arkansas
Not applicableStudy completedNCT05307926
What this trial is testing

Postoperative Adjuvant Therapy of HCC Based on PD-1

Who this might be right for
Hepatocellular CarcinomaRFS
Chen Xiaoping 573
Not applicableWithdrawnNCT00624962
What this trial is testing

Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsKidney CancerLeukemia+4 more
Vanderbilt University
Large-scale testing (Phase 3)Not Yet RecruitingNCT07284394
What this trial is testing

Liver-directed Chemotherapy After Surgery of Liver Metastases of Colorectal Cancer in Patients With High Risk of Recurrence of Their Disease

Who this might be right for
Colorectal Adenocarcinoma Metastatic in the LiverColorectal Cancer
UNICANCER 272
Not applicableLooking for participantsNCT06447064
What this trial is testing

Cancer Loyalty Card Study 2 (CLOCS-2)

Who this might be right for
Pancreatic CancerColon CancerOesophageal Cancer+7 more
Imperial College London 2,900
Large-scale testing (Phase 3)UnknownNCT03859128
What this trial is testing

Toripalimab or Placebo as Adjuvant Therapy in Hepatocellular Carcinoma After Radical Resection

Who this might be right for
Hepatocellular Carcinoma
Shanghai Junshi Bioscience Co., Ltd. 402
Not applicableLooking for participantsNCT07160946
What this trial is testing

Risk Assessment for HBV-Related Liver Cancer

Who this might be right for
HBV-related Liver Cirrhosis
Sun Yat-sen University 6,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128290
What this trial is testing

PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Federation Francophone de Cancerologie Digestive 49
Not applicableUnknownNCT03838796
What this trial is testing

Lenvatinib Combined With TACE to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 297
Not applicableActive Not RecruitingNCT06699524
What this trial is testing

Construction of a Recurrence Risk Prediction Model for Liver Resection Based on Drug Sensitivity of Patient-derived Hepatocellular Carcinoma Organoid

Who this might be right for
Hepatocellular Carcinoma
Shen Feng 122
Not applicableStudy completedNCT02798224
What this trial is testing

A Patient Portal Tool, E-assist, for Supporting CRC Screening

Who this might be right for
Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center 1,826
Not applicableUnknownNCT03110068
What this trial is testing

Preoperative Estimation of Microvascular Invasion in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Ming Kuang 370
Not applicableLooking for participantsNCT07169656
What this trial is testing

Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.

Who this might be right for
Chronic Hepatitis b
The First Affiliated Hospital of Zhengzhou University 15,000
Not applicableEnrolling By InvitationNCT05429190
What this trial is testing

Validation of SMS Protocol for HCC Screening in High-risk Patients

Who this might be right for
Hepatocellular Carcinoma
Erasmus Medical Center 470
Testing effectiveness (Phase 2)UnknownNCT05545124
What this trial is testing

Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of Recurrence

Who this might be right for
Hepatocellular Carcinoma
Henan Cancer Hospital 32
Large-scale testing (Phase 3)Study completedNCT02494973
What this trial is testing

Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases

Who this might be right for
Colorectal Cancer
Gustave Roussy, Cancer Campus, Grand Paris 104
Not applicableStudy completedNCT04802954
What this trial is testing

Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients

Who this might be right for
Hepatocellular CarcinomaChronic Liver Disease
IHU Strasbourg 400
Early research (Phase 1)Ended earlyNCT00003926
What this trial is testing

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorChordoma+6 more
Masonic Cancer Center, University of Minnesota 13
Not applicableUnknownNCT05721300
What this trial is testing

Study on Screening, Verification and Intervention of High-risk Patients With Liver Cancer

Who this might be right for
Hepatocellular CarcinomaChronic Hepatitis B
Zhongshan Hospital (Xiamen), Fudan University 2,215
Load More Results